Lyka Labs Limited (LYKALABS.BO)
INR 157.15
(2.23%)
INR 157.15
(2.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 586.5 Million INR | -20.4% |
| 2022 | 736.82 Million INR | -42.99% |
| 2021 | 1.29 Billion INR | -20.53% |
| 2020 | 1.62 Billion INR | 14.21% |
| 2019 | 1.42 Billion INR | 49.06% |
| 2018 | 955.28 Million INR | -14.56% |
| 2017 | 1.11 Billion INR | -10.4% |
| 2016 | 1.24 Billion INR | 10.58% |
| 2015 | 1.12 Billion INR | 27.11% |
| 2014 | 887.72 Million INR | -28.53% |
| 2013 | 1.24 Billion INR | -1.43% |
| 2012 | 1.26 Billion INR | 5.54% |
| 2011 | 1.19 Billion INR | 4.32% |
| 2010 | 1.14 Billion INR | 4.98% |
| 2009 | 1.09 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 586.5 Million INR | 0.0% |
| 2023 Q2 | 540.62 Million INR | 0.0% |
| 2023 FY | 586.5 Million INR | -20.4% |
| 2022 Q2 | 1.29 Billion INR | 0.0% |
| 2022 FY | 736.82 Million INR | -42.99% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 736.82 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.29 Billion INR | 0.0% |
| 2021 FY | 1.29 Billion INR | -20.53% |
| 2021 Q2 | 1.24 Billion INR | 0.0% |
| 2020 Q4 | 1.62 Billion INR | 0.0% |
| 2020 FY | 1.62 Billion INR | 14.21% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.48 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 1.42 Billion INR | 0.0% |
| 2019 FY | 1.42 Billion INR | 49.06% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 928.79 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 955.28 Million INR | 0.0% |
| 2018 FY | 955.28 Million INR | -14.56% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 1.11 Billion INR | -10.4% |
| 2016 FY | 1.24 Billion INR | 10.58% |
| 2016 Q4 | 852.39 Million INR | 0.0% |
| 2016 Q2 | 902.18 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 FY | 1.12 Billion INR | 27.11% |
| 2015 Q4 | 1.22 Billion INR | 68.38% |
| 2015 Q3 | 725.08 Million INR | 0.0% |
| 2015 Q2 | 725.08 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | 1.17 Billion INR | 0.0% |
| 2014 Q4 | 1.38 Billion INR | 0.0% |
| 2014 FY | 887.72 Million INR | -28.53% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 1.27 Billion INR | 0.0% |
| 2013 FY | 1.24 Billion INR | -1.43% |
| 2012 Q4 | 1.26 Billion INR | 0.0% |
| 2012 FY | 1.26 Billion INR | 5.54% |
| 2011 FY | 1.19 Billion INR | 4.32% |
| 2010 FY | 1.14 Billion INR | 4.98% |
| 2009 FY | 1.09 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 56.763% |
| Biocon Limited | 162.76 Billion INR | 99.64% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -3536.088% |
| Concord Biotech Limited | 97.37 Million INR | -502.305% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 97.464% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 55.659% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Panacea Biotec Limited | 209.9 Million INR | -179.419% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | -2562.042% |
| Servoteach Industries Limited | 5059.00 INR | -11593120.004% |
| SMS Lifesciences India Limited | 1 Billion INR | 41.771% |
| Supriya Lifescience Limited | 54.88 Million INR | -968.697% |
| Syngene International Limited | 5.55 Billion INR | 89.436% |
| TAKE Solutions Limited | 370.85 Million INR | -58.15% |
| Titan Biotech Limited | 83.02 Million INR | -606.381% |
| Transgene Biotek Limited | 140.01 Million INR | -318.899% |
| Vanta Bioscience Limited | 609.53 Million INR | 3.779% |